| （単位：千ドル） | 2Q20 | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 3Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 9,287 | 11,775 | 20,696 | 24,572 | 27,581 | 26,998 | 29,106 | 27,862 | 32,345 | 30,251 | 27,893 | 20,963 | 25,026 | 30,105 | 48,179 |
| 営業費用 | 12,237 | 15,585 | 26,148 | 31,373 | 35,680 | 35,426 | 37,409 | 36,069 | 41,242 | 37,691 | 34,781 | 28,572 | 33,580 | 39,442 | 57,405 |
| 営業利益 | -12,237 | -15,585 | -26,148 | -31,373 | -35,680 | -35,426 | -37,409 | -36,069 | -41,242 | -37,691 | -34,781 | -28,572 | -33,580 | -39,442 | -57,405 |
| 経常（税引前）利益 | -12,236 | -15,637 | - | -31,294 | -35,598 | - | - | - | - | - | - | - | - | - | - |
| 法人税等合計 | 4 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 実効税率（％） | - | - | - | - | - | - | - | - | - | - | - | - | - | ||
| 純利益 | -12,240 | -15,638 | -26,006 | -31,294 | -35,598 | -35,373 | -37,137 | -35,054 | -38,676 | -35,188 | -32,482 | -25,176 | -29,610 | -34,824 | -54,356 |
| 一株あたり利益 | - | - | - | - | - | - | -0.96 | -0.51 | -0.52 | -0.47 | -0.43 | -0.21 | -0.23 | -0.25 | -0.37 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | -0.96 | -0.51 | -0.52 | -0.47 | -0.43 | -0.21 | -0.23 | -0.25 | -0.37 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |